Cleveland Clinic Study Reveals Optimal Weight Loss Strategies Post-GLP-1 Drug Discontinuation
Rapid Read

Cleveland Clinic Study Reveals Optimal Weight Loss Strategies Post-GLP-1 Drug Discontinuation

What's Happening? New research from the Cleveland Clinic, published in eClinicalMedicine, indicates that patients who discontinue injectable GLP-1 drugs like semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound) achieve the most significant two-year weight loss if they subsequently undergo
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.